Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss ...

AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving ...

Key market opportunities in the pharma 5 sector include leveraging digital health technologies, AI-driven drug discovery, and ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...

The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...

Breakthrough Properties, a premier global life science real estate developer, today announced the completion of One Helix, a fully-leased, state-of-the-art research facility within the campus of the ...

Eli Lilly and Company (NYSE:LLY) shares are trading slightly lower on Tuesday after its previous gains following reports ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss drugs at $149 per month, in exchange for Medicare coverage, Endpoints News ...

Live Updates Live Coverage Updates appear automatically as they are published. Updates will appear here as they are published. Tempus AI (NASDAQ: TEM) reports third-quarter results after the close, ...

The biggest risers on the FTSE 100 were Convatec, up 6.2 pence at 245p, Land Securities, up 12.5p at 627.5p, GSK, up 32.5p at ...

LONDON: London’s main stock indexes dipped on Monday, dragged down by materials and utilities shares, as investors prepare ...